Siemens MAMMOMAT Fusion
Manufacturer: Siemens Healthineers · Modality: Mammography
2D-only FFDM platform positioned as Siemens' screening-focused entry tier beneath Mammomat Inspiration and Mammomat Revelation. Shares the amorphous-selenium direct-conversion detector technology with the Inspiration / Revelation lineage but omits tomosynthesis and the advanced application suite to reduce footprint and cost.
Platform characteristics
- Direct-conversion a-Se detector — same physics family as Inspiration / Revelation; no phosphor conversion layer.
- 2D FFDM only — no tomosynthesis; no biopsy add-on; no contrast-enhanced mammography.
- OpComp compression — automated breast-thickness-adaptive compression assist.
- PRIME workflow — anti-scatter grid removed in software via post-processing, reducing dose without hardware grid pullout.
Specs
- Amorphous-selenium direct-conversion detector (24 × 30 cm field)
- 85 µm pixel pitch
- Tungsten anode with Rh / Ag filtration (kVp + mA program per compressed breast thickness)
- PRIME software-grid processing
- syngo Acquisition workplace host
Clinical positioning
- Screening-only sites without a tomosynthesis workflow requirement.
- International markets where 2D FFDM remains the standard of care and tomosynthesis reimbursement / regulatory adoption lags.
- Replacement of CR mammography in facilities transitioning from computed radiography to direct digital.
Relationship to siblings
- MAMMOMAT Inspiration — adds tomosynthesis and biopsy package.
- MAMMOMAT Revelation — wide-angle 50° tomosynthesis and HD breast-density / contrast-enhanced options.